Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01047878 · ClinicalTrials.gov registry record
Genomic Analysis of Pediatric Bone Tumors
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 163
- Enrollment target
NCT01047878: Completed study, sponsored by Stanford University.
NCT01047878 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 163 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01047878 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 163 participants
- Enrollment target
Study Summary
To determine whether gene expression analysis of primary tumor samples before and after chemotherapy are predictive of long-term survival in pediatric patients with bone sarcomas (Ewings sarcoma (ES) and Osteosarcoma(OS)).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2007-08 |
| Est. Completion | 2019-12 |
What the finished NCT01047878 record still lists
NCT01047878 is an observational study that tracks outcomes without assigning an intervention. The registered 163 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01047878 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01047878 about?
NCT01047878 is a clinical study titled "Genomic Analysis of Pediatric Bone Tumors". To determine whether gene expression analysis of primary tumor samples before and after chemotherapy are predictive of long-term survival in pediatric patients with bone sarcomas (Ewings sarcoma (ES) and Osteosarcoma(OS)).
What is the current status of trial NCT01047878?
This trial is currently completed. The enrollment target is 163 participants. The study started on 2007-08. Estimated completion is 2019-12.
Who is sponsoring clinical trial NCT01047878?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03180268 · 163 participants · Phase 3
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
- NCT04862221 · 163 participants · Phase 2
TReatment for ImmUne Mediated PathopHysiology
- NCT05702229 · 163 participants · Phase 2
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT06137118 · 163 participants · Phase 1
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia